Depression in neurodegenerative diseases: Common mechanisms and current treatment options
CPC Galts, LEB Bettio, DC Jewett, CC Yang… - Neuroscience & …, 2019 - Elsevier
Major depressive disorder (MDD) is a highly prevalent psychiatric disorder and a major
cause of disability worldwide. This neurological condition is commonly associated with …
cause of disability worldwide. This neurological condition is commonly associated with …
Reinforcement learning in depression: A review of computational research
C Chen, T Takahashi, S Nakagawa, T Inoue… - … & Biobehavioral Reviews, 2015 - Elsevier
Despite being considered primarily a mood disorder, major depressive disorder (MDD) is
characterized by cognitive and decision making deficits. Recent research has employed …
characterized by cognitive and decision making deficits. Recent research has employed …
Recent advances in the pathology of prodromal non-motor symptoms olfactory deficit and depression in Parkinson's disease: clues to early diagnosis and effective …
Y Bang, J Lim, HJ Choi - Archives of pharmacal research, 2021 - Springer
Parkinson's disease (PD) is a progressive neurodegenerative disease characterized by
movement dysfunction due to selective degeneration of dopaminergic neurons in the …
movement dysfunction due to selective degeneration of dopaminergic neurons in the …
Physical training prevents depressive symptoms and a decrease in brain-derived neurotrophic factor in Parkinson's disease
T Tuon, SS Valvassori, GC Dal Pont, CS Paganini… - Brain Research …, 2014 - Elsevier
Depression is a neuropsychiatric disorder that is commonly found in patients with
Parkinson's disease (PD). Many studies have suggested that physical exercise can have an …
Parkinson's disease (PD). Many studies have suggested that physical exercise can have an …
Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson's disease is mediated by a reduction of inducible nitric oxide …
MA Mori, AM Delattre, B Carabelli, C Pudell… - Nutritional …, 2018 - Taylor & Francis
Objective: Parkinson's disease (PD) is characterized by deterioration of the nigrostriatal
system and associated with chronic neuroinflammation. Glial activation has been associated …
system and associated with chronic neuroinflammation. Glial activation has been associated …
The hidden side of Parkinson's disease: Studying pain, anxiety and depression in animal models
Parkinson's disease is a neurodegenerative disease leading to the loss of midbrain
dopamine neurons. It is well known and characterized by motor symptoms that are …
dopamine neurons. It is well known and characterized by motor symptoms that are …
Dopamine receptor D3 deficiency results in chronic depression and anxiety
Over the last decade accumulating evidence suggests that brain dopamine (DA) has a role
in depression, particularly given the high comorbidity of depression with Parkinson's …
in depression, particularly given the high comorbidity of depression with Parkinson's …
What can rodent models tell us about apathy and associated neuropsychiatric symptoms in Parkinson's disease?
In addition to classical motor symptoms, Parkinson's disease (PD) patients display
incapacitating neuropsychiatric manifestations, such as apathy, anhedonia, depression and …
incapacitating neuropsychiatric manifestations, such as apathy, anhedonia, depression and …
[HTML][HTML] Mood disturbances in Parkinson's disease: From prodromal origins to application of animal models
Parkinson's disease (PD) is a complex illness with a constellation of environmental insults
and genetic vulnerabilities being implicated. Strikingly, many studies only focus on the …
and genetic vulnerabilities being implicated. Strikingly, many studies only focus on the …
Anxiety-like behavior induced by 6-OHDA animal model of Parkinson's disease may be related to a dysregulation of neurotransmitter systems in brain areas related to …
JCF Vieira, TB Bassani, RM Santiago, GO Guaita… - Behavioural brain …, 2019 - Elsevier
Anxiety in Parkinson's disease may represent a physiological reaction to the development of
other symptoms during disease progression. However, evidence suggests that the incidence …
other symptoms during disease progression. However, evidence suggests that the incidence …